Delivery Order SPE2DB20D2104-SPE2DB24FV12Y
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIGAMOX 0.5% eye drops. The delivery order, valued at $1,740.27, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award, with the ID SPE2DB20D3101|SPE2DB23FRQG7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,600.77 delivery order is for the supply of VIGAMOX 0.5% eye drops, a medical product used for various ophthalmic conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of June 27, 2023. This award is not designated as a set-aside...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6VS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2022. There is no set-aside designation mentioned for this...
- This federal contract award, valued at $2,196.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP9L2) for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,278.06 firm fixed-price delivery order is for the procurement of VIGAMOX 0.5% eye drops with an ultimate completion date of August 11, 2022. The contract supports the medical supply needs of federal agencies and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB23FVG63, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,349.62 contract is for the delivery of Vigamox 0.5% eye drops, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,873.44, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,109.20, is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 13, 2024. This award is not associated with a set-aside...
- This federal contract award, valued at $5,866.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of January 17, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,541.44 firm fixed-price delivery order is for 4566717568 - VIGAMOX 0.5% EYE DROPS 3ML, with a final completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FV12YDelivery Order
The federal contract award with ID SPE2DB20D2104|SPE2DB24FV12Y was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,538.36 contract is a firm fixed price delivery order to provide VIGAMOX 0.5% eye drops (3ml). This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/11/24 |